These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7209481)

  • 21. Drugs and sports.
    Soz Praventivmed; 1993; 38(3):180. PubMed ID: 8372497
    [No Abstract]   [Full Text] [Related]  

  • 22. Steroid abuse.
    Porterfield LM
    Adv Clin Care; 1991; 6(2):44. PubMed ID: 1998558
    [No Abstract]   [Full Text] [Related]  

  • 23. [Doping agents and their analytical control].
    Szókán G
    Acta Pharm Hung; 2002; 72(4):231-44. PubMed ID: 12812043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Limits of doping: drugs and sports].
    Kuipers H
    Ned Tijdschr Geneeskd; 1988 Nov; 132(45):2044-6. PubMed ID: 2847062
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening for 2-quinolinone-derived selective androgen receptor agonists in doping control analysis.
    Thevis M; Kohler M; Maurer J; Schlörer N; Kamber M; Schänzer W
    Rapid Commun Mass Spectrom; 2007; 21(21):3477-86. PubMed ID: 17985352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass spectrometry in sports drug testing: Structure characterization and analytical assays.
    Thevis M; Schänzer W
    Mass Spectrom Rev; 2007; 26(1):79-107. PubMed ID: 16888758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs and the athlete.
    Horwitz DL
    Compr Ther; 1982 Mar; 8(3):3-4. PubMed ID: 7067396
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids.
    Georgakopoulos CG; Vonaparti A; Stamou M; Kiousi P; Lyris E; Angelis YS; Tsoupras G; Wuest B; Nielen MW; Panderi I; Koupparis M
    Rapid Commun Mass Spectrom; 2007; 21(15):2439-46. PubMed ID: 17610244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Importance and problem of doping control in sports and toxicological analyses].
    Ueki M
    Nihon Rinsho; 1999 Sep; 57 Suppl():361-3. PubMed ID: 10543127
    [No Abstract]   [Full Text] [Related]  

  • 30. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taking a strong stance against anabolic steroid use.
    Wilkerson LA
    J Am Osteopath Assoc; 1995 Aug; 95(8):468-70. PubMed ID: 7673007
    [No Abstract]   [Full Text] [Related]  

  • 32. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control.
    Virus ED; Sobolevsky TG; Rodchenkov GM
    J Mass Spectrom; 2008 Jul; 43(7):949-57. PubMed ID: 18563856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs in sport: the extent of the problem, toxic effects, and control.
    Arblaster CI; Blackman GL
    Aust Fam Physician; 1981 Mar; 10(3):145-6, 148. PubMed ID: 7247848
    [No Abstract]   [Full Text] [Related]  

  • 34. [Doping 78].
    S'Jongers JJ
    Brux Med; 1978 Dec; (12):647-53. PubMed ID: 728819
    [No Abstract]   [Full Text] [Related]  

  • 35. [Point of view on doping].
    Naeije R; Pagnamenta A
    Rev Med Brux; 1999 Jun; 20(3):153-8. PubMed ID: 10429539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Performance stimulating measures in peak sport].
    Howald H
    Schweiz Z Sportmed; 1977; 25(4):175-83. PubMed ID: 594747
    [No Abstract]   [Full Text] [Related]  

  • 37. Sudden unexpected death in a female fitness athlete, with a possible connection to the use of anabolic androgenic steroids (AAS) and ephedrine.
    Thiblin I; Mobini-Far H; Frisk M
    Forensic Sci Int; 2009 Jan; 184(1-3):e7-11. PubMed ID: 19110387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs and food supplements in sports. The nandrolone lessons.
    Benzi G; Ceci A
    Minerva Pediatr; 2001 Oct; 53(5):395-6. PubMed ID: 11668257
    [No Abstract]   [Full Text] [Related]  

  • 39. Implementation of gas chromatography combined with simultaneously selected ion monitoring and full scan mass spectrometry in doping analysis.
    Van Thuyne W; Van Eenoo P; Delbeke FT
    J Chromatogr A; 2008 Nov; 1210(2):193-202. PubMed ID: 18849031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substance use in athletics: a sports psychiatry perspective.
    McDuff DR; Baron D
    Clin Sports Med; 2005 Oct; 24(4):885-97, ix-x. PubMed ID: 16169452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.